Molnupiravir speeds up recovery and eases long-term symptoms, but its minimal effect on hospitalizations raises questions about its broader impact on COVID-19 care. Study: Health outcomes 3 months and ...
People with acute COVID-19 who took the antiviral drug molnupiravir (Lagevrio) reported modest improvements in symptoms, less time off from work or study, and less healthcare utilization at 6 months ...
(The Center Square) – More than two years after the pandemic ended, New Hampshire lawmakers are pushing a controversial plan that would authorize pharmacists to dispense the drug ivermectin to treat ...
A Florida Republican has filed a bill to make a controversial anti-parasitic drug touted as a miracle COVID-19 cure easily available as a human medication. Rep. Jeff Holcomb, R-Spring Hill, on Sept.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback